Found 4 results
Name | Type of Offering | Accepted Date |
---|---|---|
Cortexyme, Inc.
|
D | 2018-05-31 12:57:26 |
Amount To Be Raised
$85,566,697
Associated Brokers / Dealers
N/A
CIK Number
0001662774
Filed Document
0001662774-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-05-31 12:57:26
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cortexyme, Inc.
|
D | 2016-01-05 |
Amount To Be Raised
$15,918,641
Associated Brokers / Dealers
N/A
CIK Number
0001662774
Filed Document
0001662774-16-000002
Exclusions or Exemptions
506b
Accepted Date
2016-01-05
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Cortexyme, Inc.
|
D | 2017-02-14 13:38:58 |
Amount To Be Raised
$8,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001662774
Filed Document
0001662774-17-000001
Exclusions or Exemptions
506b
Accepted Date
2017-02-14 13:38:58
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
Quince Therapeutics, Inc.
|
D | 2025-07-01 14:20:32 |
Amount To Be Raised
$21,896,618
Associated Brokers / Dealers
N/A
CIK Number
0001662774
Filed Document
0001662774-25-000035
Exclusions or Exemptions
506b
Accepted Date
2025-07-01 14:20:32
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|